| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| License and service revenue: | $0-100.0% | $6.4M | $0 | — | — |
| Research and development | $3.1M-14.6% | $3.6M-58.4% | $8.6M-63.8% | $23.7M+3.6% | $22.9M |
| General and administrative | $3.4M-35.6% | $5.3M-39.6% | $8.7M-18.7% | $10.7M-47.7% | $20.4M |
| Total operating expenses | $6.4M-27.1% | $8.8M-48.9% | $17.3M-49.8% | $34.4M-47.9% | $66.0M |
| Loss from operations | -$6.4M-160.9% | -$2.5M+85.7% | -$17.3M+49.8% | -$34.4M+47.9% | -$66.0M |
| Other (income) expense, net | -$443K-165.6% | $675K+388.5% | -$234K-114.2% | $1.6M+132.2% | $709K |
| Net loss | -$6.0M-90.7% | -$3.1M+81.6% | -$17.1M+52.7% | -$36.1M+46.0% | -$66.7M |
| Net loss per share, basic | -$490.00+41.7% | -$840.00+87.3% | -$6630.00+60.2% | -$16650.00+56.4% | -$38150.00 |
| Net loss per share, diluted | -$490.00+41.7% | -$840.00+87.3% | -$6630.00+60.2% | -$16650.00+56.4% | -$38150.00 |
| Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, basic | $12347495000.00+228.5% | $3758804000.00+46.2% | $2570620000.00+18.7% | $2166311000.00+23.9% | $1749071000.00 |
| Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, diluted | $12347495000.00+228.5% | $3758804000.00+46.2% | $2570620000.00+18.7% | $2166311000.00+23.9% | $1749071000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.